<乌鸦传媒>Man Presents With Episodic, One-Sided Facial Paralysis Uncommon presentation of MS detailed in case report Feb 21, 2023
<乌鸦传媒>Epstein-Barr/MS Link; How CBD Curtails Seizures; NIH Finds Rare Neurologic Disease News and commentary from the world of neurology and neuroscience Feb 14, 2023
<乌鸦传媒>Viruses Tied to Subsequent Dementia, Other Neurodegenerative Diseases Viral encephalitis and Alzheimer's disease showed strongest links Jan 30, 2023
<乌鸦传媒>Isolation and Dementia Risk; High-Intensity Exercise and the Brain; Migraine and MS News and commentary from the world of neurology and neuroscience Jan 17, 2023
<乌鸦传媒>Anti-CD20 Agent Gains Approval for Multiple Sclerosis FDA greenlights ublituximab for relapsing MS Dec 29, 2022
<乌鸦传媒>Pragmatic Trials May Help Increase Minority Participation in MS Research DELIVER-MS shows racial and ethnic diversity in clinical trials can be improved Nov 02, 2022
<乌鸦传媒>Higher Relapse Rate With Rituximab vs Ocrelizumab in MS Registry Data Rituximab did not show non-inferiority in comparative effectiveness study Nov 01, 2022
<乌鸦传媒>Can First MS Symptoms Be Delayed? ARISE trial investigates radiologically isolated syndrome Oct 31, 2022
<乌鸦传媒>New Evidence Sheds Light on Stem Cell Transplantation for Progressive MS Disability, relapses no better than disease-modifying drug Oct 30, 2022
<乌鸦传媒>No Excess Pregnancy, Infant Risks With Ocrelizumab for MS Major congenital anomalies, other adverse outcomes were rare Oct 28, 2022
<乌鸦传媒>Off-Label Drug Lowers Relapses in Multiple Sclerosis Study paves way for rituximab to be considered for MS in some countries Jul 21, 2022
<乌鸦传媒>Alzheimer's-Gut Links; Long COVID and ME/CFS; ALS Patient Gets Novel Brain Interface News and commentary from the world of neurology and neuroscience Jul 19, 2022
<乌鸦传媒>Sacral Neuromodulation Promising in Neurogenic Lower Urinary Dysfunction Refractory disease corrected, at least for the short term, in selected neurologic patients Jul 15, 2022
<乌鸦传媒>Therapeutic Use of Cannabis: Risks, Benefits, Legality Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
<乌鸦传媒>Patient-Reported Outcomes Similar With Extended Natalizumab Dosing Interval NOVA trial looks at 6-week dosing to reduce PML risk Jun 09, 2022
<乌鸦传媒>High Density of MS Patients in Wisconsin -- But Why? Health records show prevalence may be three times the norm in some areas Jun 07, 2022
<乌鸦传媒>Plasma NfL Linked With Cognitive Processing Speed in Relapsing MS Post hoc analysis of trial data shows inverse relationship Jun 05, 2022
<乌鸦传媒>Quit MS Drugs or Keep Going? DISCOMS trial looks at whether MS patients should stop treatment as they age Jun 05, 2022
<乌鸦传媒>Women With MS Use Social Media to Discuss Family Planning Posts offer insight into risks, experiences during pregnancy Jun 04, 2022
<乌鸦传媒>Silent Progression in Relapsing MS Tied to Brain Volume Loss Findings highlight the need to better stratify MS patients in clinical practice May 16, 2022
<乌鸦传媒>White MS Prevalence Predominance Debunked Burden of multiple sclerosis in Black Americans under-recognized for decades, researchers say Apr 29, 2022
<乌鸦传媒>Keto Diet Bettered Fatigue, Depression in MS Quality of life, disability showed improvements in phase II study Apr 28, 2022
<乌鸦传媒>More Severe Multiple Sclerosis Seen Further North MS patients in higher latitudes experience faster decline Apr 18, 2022
<乌鸦传媒>Sleep and Light Exposure; Patients Protest CMS Plan; Lamotrigine's Cardiac Risks? News and commentary from the world of neurology and neuroscience Mar 15, 2022
<乌鸦传媒>MS Patients on Cladribine Show Fewer Relapses Real-world data analysis compares oral disease-modifying therapies Mar 01, 2022
<乌鸦传媒>Stem Cell Transplantation Shows Benefits in Aggressive MS No new relapses recorded after autologous transplant Feb 28, 2022
<乌鸦传媒>Deep Learning Identifies PPMS Patients Who May Respond to Treatment Predictive enrichment could increase the power of future trials Feb 27, 2022
<乌鸦传媒>Paramagnetic Rim Lesions Highly Specific in MS Diagnosis Sensitivity, accuracy also high in prospective study Feb 26, 2022
<乌鸦传媒>COVID Vax Response Still Impaired in Some MS Patients After Third Shot Subset of multiple sclerosis patients seroconverted after third dose, however Feb 25, 2022
<乌鸦传媒>Cialis and Brain Blood Flow; Sleep and Media Use; Can Tarantulas Solve Chronic Pain? News and commentary from the world of neurology and neuroscience Feb 15, 2022
<乌鸦传媒>MS Risk Skyrockets After Epstein-Barr Virus, but Not Other Infections Findings show "compelling evidence of causality" Jan 13, 2022
<乌鸦传媒>Worse COVID-19 Outcomes for Disabled MS Patients But monoclonal antibodies offer hope for high-risk people, registry data show Nov 02, 2021
<乌鸦传媒>MS Treatment: Early Aggressive or Escalation Therapy? Clinical trial, observational data may not be enough to decide best strategy Nov 01, 2021
<乌鸦传媒>New MS Drug Does Not Appear to Increase COVID Severity Most COVID cases were mild or moderate in patients treated with ofatumumab Oct 29, 2021
<乌鸦传媒>Cannabis Use Common Among People With MS Most don't ask for medical guidance, survey shows Oct 28, 2021
<乌鸦传媒>How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<乌鸦传媒>Frequent MRI May Spot Active Secondary Progressive MS More Quickly "If you rely on having a clinical relapse, you may wait a long time" Oct 19, 2021
<乌鸦传媒>HCQ and MS; Guillain-Barre and COVID Vax; Neural Fingerprints Can Tell Who You Are News and commentary from the world of neurology and neuroscience Oct 19, 2021
<乌鸦传媒>COVID Vaccine Response Varies With MS Treatment Type How this relates to infection outcomes or risk of infecting others is unknown Oct 18, 2021
<乌鸦传媒>Quitting Smoking Tied to Slower Motor Decline in Multiple Sclerosis Analysis suggests smoking cessation has benefits in MS Oct 17, 2021
